BD, Hamilton Collaborate to Standardize Single-Cell Multiomics Experiments Using Robotics
BD announced a collaboration agreement with Hamilton, a leading global manufacturer of laboratory automation technology, to develop automated applications together with robotics-compatible reagent kits to enable greater standardization and reduce human error when conducting large-scale single-cell multiomics experiments.
BD Launches New Robotic System to Automate Clinical Flow Cytometry
BD announced the worldwide commercial launch of a new automated instrument that prepares samples for clinical diagnostics using flow cytometry, enabling a complete “walkaway” workflow solution designed to improve standardization and reproducibility in cellular diagnostics.
BD Launches World's First Spectral Cell Sorter with High-Speed Cell Imaging
BD announced the worldwide commercial launch of the BD FACSDiscover™ S8 Cell Sorter, a new-to-world cell sorting instrument featuring two breakthrough technologies that enable researchers to uncover more detailed information about cells that was previously invisible in traditional flow cytometry experiments.
BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific Discovery
The BD Rhapsody™ HT Xpress System enables scientists to isolate, barcode and analyze single cells at a high sample throughput — up to eight times more cells than prior versions of BD single-cell analyzers.
BD Launches State-of-the-Art Cloud Software Solution to Streamline Flow Cytometry Research
Flow cytometry is an essential tool used to analyze single cells based on their characteristics, letting scientists study them in more detail to better understand health and disease. Traditional flow cytometry workflows can be inefficient, time consuming and involve many incompatible systems.
The Next Frontier: New BD Cell Sorter Will Provide Scientists Unprecedented Access to Insights into Health and Disease
Innovation is the engine that drives the life sciences. And since the 1970s when BD first pioneered flow cytometry—which remains one of the most powerful tools for life scientists, allowing them to study cells to better understand changes linked to disease—BD has remained at the forefront, developing increasingly sophisticated and capable technologies that enable scientists to gain deeper insights that have led to new and more effective treatments for humanity.
New BD Assay Advances Immunology Research Capabilities in the Developing Field of Multiomics
BD Rhapsody™ TCR/BCR Multiomic Assay speeds discovery in autoimmune disorders, immuno-oncology and infectious diseases.
BD Biosciences Introduces BD CellView™ Image Technology: A Breakthrough Innovation to Help Accelerate the Pace of Research and Enable New Therapeutic Discovery
BD Biosciences announced that a study conducted in collaboration with the European Molecular Biology Laboratory (EMBL) and published as the cover story of the January 21st issue of the journal Science profiles a new BD innovation in flow cytometry that adds fluorescence imaging and image-based decisioning to sort individual cells at exceptionally high speed, based on the visual details of each cell and not solely on the type or quantity of biomarkers that are present.
New BD Cell Analyzer Includes Spectral Analysis Capabilities
The new BD FACSymphony™ A5 SE Cell Analyzer is a fluorescence-activated, spectral-enabled cell analyzer that offers researchers the ability to choose between spectral or compensation-based cell analysis to meet different flow cytometry needs..
New BD Benchtop Cell Analyzer Enhances Laboratory Access and Accelerates Scientific Research
The new BD FACSymphony™ A1 Cell Analyzer is a fluorescence-activated cell analyzer that offers advanced research capabilities in a compact design, which helps improve
access to instrumentation for complex scientific research to more labs.
